Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aemetis is an industrial biotechnology company focused on the production of renewable fuels and biochemicals to replace traditional petroleum-based products. The company operates a diverse portfolio of assets, including a high-grade ethanol plant in California, a biodiesel facility in India, and an expanding network of renewable natural gas (RNG) dairy digesters. Aemetis is currently developing its "Carbon Zero" production platform, which aims to produce sustainable aviation fuel (SAF) and renewable diesel using carbon capture and sequestration technology. While primarily focused on the energy sector, the company produces USP-grade alcohol for the pharmaceutical and healthcare industries, demonstrating its versatility in high-purity biochemical manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aemetis.